Cohance Lifesciences Clarifies Volume Movement

Cohance Lifesciences Ltd has responded to a BSE email seeking clarification on recent unusual trading volume in its shares. The company stated that there is no pending information or announcement that requires disclosure under SEBI Listing Regulations which could explain the volume behavior. They confirmed that all Unpublished Price Sensitive Information (UPSI) has been disclosed as and when required, in compliance with regulations. This clarification addresses potential market speculation regarding the stock's recent activity.